The ROE as of December 2025 (TTM) for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) is 5.33%

According to Dawnrays Pharmaceutical (Holdings) Limited’s latest financial reports and current stock price. The company's current ROE is 5.33%. This represents a change of -6.86% compared to the average of 5.72% of the last 4 quarters.

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) Historical ROE (quarterly & annually)

How has 2348.HK ROE performed in the past?

The mean historical ROE of Dawnrays Pharmaceutical (Holdings) Limited over the last ten years is 15.08%. The current 5.33% ROE has changed -64.68% with respect to the historical average. Over the past ten years (40 quarters), 2348.HK's ROE was at its highest in in the June 2024 quarter at 15.09%. The ROE was at its lowest in in the June 2006 quarter at 0%.

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Dawnrays Pharmaceutical (Holdings) Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) Average ROE

How has 2348.HK ROE performed in the past?

The current ROE of Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) ROE vs. Peers

How is 2348.HK’s ROE compared to its peers?

Dawnrays Pharmaceutical (Holdings) Limited’s ROE is less than Chia Tai Enterprises International Limited (10.78%), less than Chaoju Eye Care Holdings Limited (7.38%), less than Jilin Province Huinan Changlong Bio-pharmacy Company Limited (10.88%), less than JBM (Healthcare) Limited (20.10%), less than Lee's Pharmaceutical Holdings Limited (5.44%), less than Essex Bio-Technology Limited (14.24%), less than Rici Healthcare Holdings Limited (17.50%), greater than Zhaoke Ophthalmology Limited (-15.44%), less than Golden Throat Holdings Group Company Limited (20.05%), greater than Sipai Health Technology Co., Ltd. (-28.58%),

Build a custom stock screener for Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dawnrays Pharmaceutical (Holdings) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dawnrays Pharmaceutical (Holdings) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.